ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,118Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 273

$621K Total Retail Price of All Prescriptions

Rank: 40 out of 273

737 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 737 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

2% of this provider’s 737 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

0% of this provider’s 9,786 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
ATORVASTATIN CALCIUM 1,301 1,157 1 8
AMLODIPINE BESYLATE 1,099 1,016 2 2
METOPROLOL SUCCINATE 860 768 3 1
LOSARTAN POTASSIUM 726 650 4 19
WARFARIN SODIUM 710 614 5 7
RAMIPRIL 702 578 6 24
CARVEDILOL 586 503 7 3
SPIRONOLACTONE 425 364 8 20
HYDROCHLOROTHIAZIDE 408 361 9 16
FUROSEMIDE 399 328 10 5
BENAZEPRIL HCL 345 316 11 35
SIMVASTATIN 340 317 12 6
PRAVASTATIN SODIUM 339 308 13 11
TORSEMIDE 171 163 14 65
XARELTO 169 163 15 61
DIGOXIN 169 135 15 15
PANTOPRAZOLE SODIUM 141 129 17 41
PLAVIX 136 123 18 12
CLOPIDOGREL 136 129 18 9
METOPROLOL TARTRATE 127 115 20 10
FENOFIBRATE 126 98 21 34
PRADAXA 89 89 22 22
EPLERENONE 85 83 23 189
ATENOLOL 84 70 24 17
AMIODARONE HCL 71 70 25 23
CRESTOR 69 61 26 14
OMEPRAZOLE 61 59 27 33
LIPITOR 61 47 27 29
MULTAQ 60 57 29 52
ISOSORBIDE MONONITRATE ER 54 41 30 13
DOXAZOSIN MESYLATE 52 52 31 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.